Of note, the rates of TOP1 and CDH3 positivity were the highest in BRCA1-related breast carcinomas (48%) followed by BRCA2-related (24%) and sporadic breast carcinomas (7%). The gene discussed is TOP1; the disease is breast carcinoma.